Emtricitabine / Tenofovir Alafenamide

Common brands: Descovy, Truvada, Viread, Biktarvy, Tivicay

Top reporter: Gilead Sciences, Inc.

Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Cytochrome P450 3A Inhibitor [EPC]Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]Protease Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
11,121
Total Reports
6,960
Serious Reports
360
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (3.24%)

Patient Demographics

Male
7,963
Female
2,425

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Emtricitabine / Tenofovir Alafenamide.

# Reaction Reports % of Total
1 BONE DENSITY DECREASED 4,815
12.0%
2 CHRONIC KIDNEY DISEASE 2,856
7.1%
3 BONE LOSS 2,629
6.5%
4 OSTEONECROSIS 2,602
6.5%
5 MULTIPLE FRACTURES 2,430
6.0%
6 TOOTH LOSS 2,296
5.7%
7 OSTEOPOROSIS 2,265
5.6%
8 RENAL FAILURE 2,227
5.5%
9 PAIN 2,014
5.0%
10 EMOTIONAL DISTRESS 1,924
4.8%
11 RENAL INJURY 1,877
4.7%
12 ANXIETY 1,779
4.4%
13 ANHEDONIA 1,700
4.2%
14 SKELETAL INJURY 1,623
4.0%
15 OSTEOPENIA 1,498
3.7%
16 ACUTE KIDNEY INJURY 637
1.6%
17 RENAL IMPAIRMENT 624
1.6%
18 BLOOD CREATININE INCREASED 593
1.5%
19 ECONOMIC PROBLEM 589
1.5%
20 TOOTH INJURY 370
0.9%
21 FRACTURE 341
0.8%
22 VITAMIN D DEFICIENCY 339
0.8%
23 BONE DENSITY ABNORMAL 337
0.8%
24 DEPRESSION 301
0.7%
25 NEPHROPATHY 289
0.7%
26 FOOT FRACTURE 278
0.7%
27 FATIGUE 250
0.6%
28 BONE DEMINERALISATION 239
0.6%
29 DEATH 229
0.6%
30 ARTHRALGIA 220
0.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.